73
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Circadian pattern and the effect of standardized physical exercise on procollagen IIA N-peptide (PIIANP) in rheumatoid arthritis at different stages and in healthy individuals

, , , , &
Pages 80-85 | Received 13 Jul 2009, Accepted 01 Sep 2009, Published online: 09 Oct 2009

References

  • Aigner T, Zhu Y, Chansky HH, Matsen FA, Maloney WJ, Sandell LJ. (1999). Re-expression of type IIA procollagen by adult articular chondrocytes in osteoarthritic cartilage. Arthritis Rheum 42:1443–50.
  • Andersson MLE, Petersson IF, Karlsson KE, Jonsson EN, Månsson B, Heinegard D, Saxne T. (2006a). Diurnal variation in serum levels of cartilage oligomeric matrix protein in patients with knee osteoarthritis. Ann Rheum Dis 65:1490–4.
  • Andersson MLE, Thorstensson CA, Roos EM, Petersson IF, Heinegård D, Saxne T. (2006b). Serum levels of cartilage oligomeric matrix protein (COMP) increase temporarily after physical exercise in patients with knee osteoarthritis. BMC Musculoskelet Disord 7:98.
  • Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS et al. (1988). The American Rheumatism Association 1987 Revised Criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–24.
  • Christensen AF, Lottenburger T, Lindegaard H, Christgau S, Hørslev-Petersen K, Junker P. (2009). Differential association of the N-propeptide of collagen IIA (PIIANP) and the collagen II C-telopeptide (CTX-II) with synovitis and erosions in early and longstanding rheumatoid arthritis. Clin Exp Rheumatol 27:307–14.
  • Christgau S, Garnero P, Fledelius C, Moniz C, Ensig M, Gineyts E, Rosenquist C, Qvist P. (2001). Collagen type II C-telopeptide fragments as an index of cartilage degradation. Bone 29:209–15.
  • Engström-Laurent A, Hällgren R. (1987). Circulating hyaluronic acid levels vary with physical activity in healthy subjects and in rheumatoid arthritis patients. relationship to synovitis mass and morning stiffness. Arthritis Rheum 30: 1333–1338.
  • Garnero P, Rousseau JC, Delmas PD. (2000). Molecular basis and clinical use of biochemical markers of bone, cartilage, and synovium in joint disease. Arthritis Rheum 43:953–68.
  • Høier-Madsen M, Nielsen LP, Møller S. (1986). Determination of IgM rheumatoid factors by enzyme-linked immunosorbent assay (ELISA). Ugeskr Laeger 148:2018–21.
  • Kong SY, Stabler TV, Criscione LG, Elliott AL, Jordan JM, Kraus VB. (2006). Diurnal variation of serum and urine biomarkers in patients with radiographic knee osteoarthritis. Arthritis Rheum 54:2496–505.
  • Larsen A, Dale K, Eek M. (1977). Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiol Diagn Stockh 18:481–91.
  • Lui V, Ng J, Nicholls J, Tam P, Cheah K. (1995). Tissue-specific and differential expression of alternatively spliced alpha1(II) collagen MRNAs in early human embryos. Dev Dyn 203:198–211.
  • Manicourt DH, Poilvache P, Nzeusseu A, van Egeren A, Devogelaer JP, Lenz ME, Thonar EJ. (1999). Serum levels of hyaluronan, antigenic keratan sulfate, matrix metalloproteinase 3, and tissue inhibitor of meatalloproteinase 1 change predictably in rheumatoid arthritis patients who have begun activity after a night of bed rest. Arthritis Rheum 42:1861–9.
  • Oganesian A, Zhu Y, Sandell L J. (1997). Type IIA procollagen amino propeptide is localized in human embryonic tissues. J Histochem Cytochem 45:1469–80.
  • Quintana DJ, Garnero P, Huebner JL, Charni-Ben Tabassi N, Kraus VB. (2008). PIIANP and HELIXII diurnal variation. Osteoarthritis Cartilage 16:1192–5.
  • Rousseau JC, Zhu Y, Miossec P, Vignon E, Sandell LJ, Garnero P, Delmas PD. (2004). Serum levels of type IIA procollagen amino terminal propeptide (PIIANP) are decreased in patients with knee osteoarthritis and rheumatoid arthritis. Osteoarthritis Cartilage 12:440–7.
  • Ryan MC, Sandell LJ. (1990). Differential expression of a cysteine-rich domain in the amino-terminal propeptide of type II (cartilage) procollagen by alternative splicing of MRNA. J Biol Chem 265:10334–9.
  • Sandell LJ, Morris N, Robbins JR, Goldring MB. (1991). Alternatively spliced type II procollagen MRNAs define distinct populations of cells during vertebral development: differential expression of the amino-propeptide. J Cell Biol 114:1307–19.
  • Sharif M, Kirwan J, Charni N, Sandell LJ, Whittles C, Garnero P. (2007). A 5-yr longitudinal study of type IIA collagen synthesis and total type II collagen degradation in patients with knee osteoarthritis – association with disease progression. Rheumatology 46:938–43.
  • Thorsen H, Hansen TM, Mckenna SP, Sørensen SF, Whalley D. (2001). Adaption into Danish of the Stanford Health Assessment Questionnaire (HAQ) and the Rheumatoid Arthritis Quality of Life Scale (RaQol). Scand J Rheumatol 30:103–9.
  • van Riel PL, Scott DL. (2004). Eular Handbook of Clinical Assessments in Rheumatoid Arthritis. The Netherlands: Van Zuiden Communications BV.
  • Zhu Y, McAlinden A, Sandell LJ. (2001). Type IIA procollagen in development of the human intervertebral disc: regulated expression of the NH2-propeptide by enzymic processing reveals a unique developmental pathway. Dev Dyn 220:350–62.
  • Zhu Y, Oganesian A, Keene DR, Sandell LJ. (1999). Type IIA procollagen containing the cysteine-rich amino propeptide is deposited in the extracellular matrix of prechondrogenic tissue and binds to TGF-beta 1 and BMP-2. J Cell Biol 144:1069–80.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.